| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 09/04/2002 | EP1235776A1 Triphenylalkene derivatives and their use as selective estrogen receptor modulators |
| 09/04/2002 | EP1235618A2 Bioconjugation in vivo to pulmonary or blood components |
| 09/04/2002 | EP1235598A2 Compositions of a combination of radioactive therapy and cell-cycle inhibitors |
| 09/04/2002 | EP1235597A2 Nucleic acid delivery system |
| 09/04/2002 | EP1235595A2 Integrin-mediated drug targeting |
| 09/04/2002 | EP1235593A2 Hyperoncotic artificial cerebrospinal fluid and method of treating neural tissue edema therewith |
| 09/04/2002 | EP1235581A2 Use of ribose to prevent cramping and soreness in muscles |
| 09/04/2002 | EP1235580A2 Transdermal system containing acetylsalicylic acid for treatment of migraine |
| 09/04/2002 | EP1235579A1 Pharmaceutical compositions comprising trimegestone |
| 09/04/2002 | EP1235578A2 Use of hymenialdisine or derivatives thereof in the manufacture of medicaments |
| 09/04/2002 | EP1235577A2 Protease inhibitors |
| 09/04/2002 | EP1235576A2 Combinations of sumatriptan or naratriptan with cyclooxygenase ii inhibitor |
| 09/04/2002 | EP1235575A2 Agent for expression of long-term potentiation of synaptic transmission comprising compound having brain somatostatin activation property |
| 09/04/2002 | EP1235574A2 Methods for making sustained-release pharmaceutical compositions of ergot alkaloids having improved bioavailability and compositions thereof |
| 09/04/2002 | EP1235573A2 Combination of riluzole and gabapentin and use thereof as medicine |
| 09/04/2002 | EP1235572A2 Method to treat pain utilizing benzimidazole nmda/nr2b antagonists |
| 09/04/2002 | EP1235571A1 Use of melatonin for treating androgenetic and diffuse alopecia |
| 09/04/2002 | EP1235570A2 Combinations of (s)-2-(benzylamino-methyl)-2,3,8,9,-tetrahydro-7h-1,4-dioxino(2,3)-e indol-8-one and neuroleptics |
| 09/04/2002 | EP1235569A2 Medicament and combination of compatible medicaments |
| 09/04/2002 | EP1235568A2 Depletion of cellular coenzyme-a levels as a means to selectively kill cancer cells |
| 09/04/2002 | EP1235567A2 Inhibitors of collagen-induced platelet aggregation |
| 09/04/2002 | EP1235566A2 Valnemulin formulation |
| 09/04/2002 | EP1235565A1 Use of 5ht 3 agonists for relaxing the fundus |
| 09/04/2002 | EP1235563A2 Use of anti(w)pressor agents for vascular remodeling in genital dysfunction |
| 09/04/2002 | EP1235562A1 Chronotherapeutic diltiazem formulations and the administration thereof |
| 09/04/2002 | EP1235558A2 Compressed tablet composition comprising a nsaid |
| 09/04/2002 | EP1235557A2 Gastroretentive controlled release pharmaceutical dosage forms |
| 09/04/2002 | EP1235555A2 Stable galenic preparations comprising a benzimidazol and method for the production thereof |
| 09/04/2002 | EP1169314B1 Crystalline base of citalopram |
| 09/04/2002 | EP1150974B1 Heterocyclic derivatives as inhibitors of factor xa |
| 09/04/2002 | EP1140919B1 1,4-disubstituted cyclohexane derivatives for the treatment of depression |
| 09/04/2002 | EP1091951B1 Novel polyoxypropylenepolyoxyethylene vitamin e and preparation thereof |
| 09/04/2002 | EP1080086B1 Dihydropyrimidines |
| 09/04/2002 | EP1068184B1 N-aryloxyethylamine derivatives for the treatment of depression |
| 09/04/2002 | EP1056759B1 2-(purin-9-yl) -tetrahydrofuran-3, 4-diol derivatives |
| 09/04/2002 | EP1056736B1 Alternate method for acylating 10-deacetylbaccatin iii selectively at the c-10 position |
| 09/04/2002 | EP1054886B1 Heteroaryl amidines, methylamidines and guanidines as protease inhibitors, in particular as urokinase inhibitors |
| 09/04/2002 | EP1049478B1 Composition containing propargylamine for enhancing cancer therapy |
| 09/04/2002 | EP1041975B1 Rate controlling membranes for controlled drug delivery devices |
| 09/04/2002 | EP1041972B1 Tablet for instant and prolonged release of one or more active substances |
| 09/04/2002 | EP1037888B1 (e)-3-[1-n-butyl- 5-[2-(2-carboxyphenyl)methoxy- 4-chlorophenyl]-1h- pyrazol-4-yl]-2- [(5- methoxy-2,3- dihydrobenzofuran-6-yl)methyl]- prop-2-enoic acid monoargininyl salt |
| 09/04/2002 | EP1036076B1 Novel compounds |
| 09/04/2002 | EP1005471B1 Pyrazolo(3,4-d)pyrimidines with anticonvulsive and antiallergic/antiasthmatic action |
| 09/04/2002 | EP1004307B1 Ophthalmic composition |
| 09/04/2002 | EP0999849B1 Use of lbp in the treatment of septicaemia |
| 09/04/2002 | EP0991647B1 Eprosartan monohydrate |
| 09/04/2002 | EP0969828B1 Butyrate prodrugs derived from lactic acid |
| 09/04/2002 | EP0966476B1 Quinazolinone compounds |
| 09/04/2002 | EP0949923B1 Stabilised pharmaceutical compositions, based on quinupristine and dalfopristine, and their preparation |
| 09/04/2002 | EP0944629B1 Biaryl-pyridoquinazolinone derivatives as anti-cancer agents |
| 09/04/2002 | EP0934278B1 Bis(acridinecarboxamide) and bis(phenazinecarboxamide) as antitumour agents |
| 09/04/2002 | EP0932389B1 Ophthalmic compositions containing a carbonic anhydrase inhibitor and xanthan gum |
| 09/04/2002 | EP0930879B1 Use of calcium dobesilate for the manufacture of a medicament for the treatment of embryonic retardation |
| 09/04/2002 | EP0929525B1 Heteroaryloxyethylamines as 5-ht1a receptor ligands |
| 09/04/2002 | EP0920447B1 Process of purification of cyclosporin |
| 09/04/2002 | EP0920418B1 Substituted imidazolium salts and their use for the inhibition of protein ageing |
| 09/04/2002 | EP0920309B1 Conjugated linoleic acid to maintain or enhance bone mineral content |
| 09/04/2002 | EP0915864B1 Gastroprotective flavone/flavanone compounds with therapeutic effect on inflammatory bowel disease |
| 09/04/2002 | EP0913151B1 Anti-helicobacter pylori compositions containing 1-methylcarbapenem derivatives as the active ingredient |
| 09/04/2002 | EP0906309B1 Modified form of the r(-)-n-(4,4-di(3-methylthien-2-yl)but-3-enyl)-nipecotic acid hydrochloride |
| 09/04/2002 | EP0904095B1 Chimeric isoprenoid synthases and uses thereof |
| 09/04/2002 | EP0904063B1 Process for the preparation of microparticles |
| 09/04/2002 | EP0889878B1 Bisarylcyclobutene derivates as cyclooxygenase inhibitors |
| 09/04/2002 | EP0858459B1 Novel acid pyrazole derivatives, preparation method therefor, use thereof as drugs, novel use therefor, and pharmaceutical compositions containing such derivatives |
| 09/04/2002 | EP0847397B1 water-soluble c-ring analogues of 20 (s)-camptothecin |
| 09/04/2002 | EP0835098B1 New, stable medicinal compositions for generating propellant-free aerosols |
| 09/04/2002 | EP0832074B1 Amino acid derivatives of substituted quinoxaline 2,3-dione derivatives as glutamate receptor antagonists |
| 09/04/2002 | EP0830348B1 Cyclic amine derivatives of substituted quinoxaline 2,3-diones as glutamate receptor antagonists |
| 09/04/2002 | EP0814844B1 Thyroxine/cyclodextrin complexes and pharmaceutical compositions containing the same |
| 09/04/2002 | EP0809636B1 Substituted isoxazoles for the treatment of inflammation |
| 09/04/2002 | EP0801571B1 Soluble 2-chloro-2'-deoxyadenosine formulations |
| 09/04/2002 | EP0792143B1 Methods for making liposomes containing hydrophobic drugs |
| 09/04/2002 | EP0789590B1 Chitosan induced immunopotentiation |
| 09/04/2002 | EP0783884B1 Conagenin as preventive and remedy for diarrhea |
| 09/04/2002 | EP0775143B1 3-substituted 3h-2,3-benzodiazepine derivatives, their preparation and use as medicaments |
| 09/04/2002 | EP0771209B1 Novel peptides |
| 09/04/2002 | EP0760664B1 Use of pteridine derivatives as no-synthase inhibitors |
| 09/04/2002 | EP0755443B1 Tissue-specific enhancer active in prostate |
| 09/04/2002 | EP0746551B1 Optically pure 4-aryl-2-hydroxytetronic acids |
| 09/04/2002 | EP0738107B1 Inhibitors of fatty acid synthesis as antimicrobial agents |
| 09/04/2002 | EP0724587B1 Ring-expanded nucleosides and nucleotides |
| 09/04/2002 | EP0702723B1 Biocompatible implant for the expression and secretion in vivo of a therapeutical compound |
| 09/04/2002 | EP0700397B1 New thiazolidindiones and drugs containing them |
| 09/04/2002 | EP0683669B1 Methods and compositions of a polymer (poloxamer) for cell repair |
| 09/04/2002 | EP0644880B1 1,2,3-triazole and imidazole compounds and their antitumor use |
| 09/04/2002 | EP0635008B1 Piperazides of substituted phenylalanine derivates as thrombin inhibitors |
| 09/04/2002 | CN1367830A Cancer associated antigens and uses therefor |
| 09/04/2002 | CN1367829A Compositions and methods for therapy and diagnosis of lung cancer |
| 09/04/2002 | CN1367828A Oligonucleotides for inhibiting expression of human eg5 |
| 09/04/2002 | CN1367816A Fat compositions |
| 09/04/2002 | CN1367790A Moraxella cattarrhalis BASB114 polypeptide antigens and uses thereof |
| 09/04/2002 | CN1367787A Water soluble SDZ-RAD esters |
| 09/04/2002 | CN1367786A Method for preparation of citalopram |
| 09/04/2002 | CN1367785A Heterocyclic carboxamide-containing thiourea inhibitors of herpes viruses containing substituted phenylenediamine group |
| 09/04/2002 | CN1367783A Antipsychotic cyclic N-aralkyl amines |
| 09/04/2002 | CN1367782A Process for producing dibenzothiazepine derivatives |
| 09/04/2002 | CN1367780A Oxazolidinones and their preparing method and use thereof |
| 09/04/2002 | CN1367778A Novel carboxylic acid derivatives with 5,6 substitutedpyrimidine ring, their production and utilization thereof as endothelin receptor antagonists |
| 09/04/2002 | CN1367777A Benzenamine derivatives as anti-coagulants |
| 09/04/2002 | CN1367775A Cubane derivatives as metabotropic glutamate receptor antagonists and process for their preparation |